Peter Barabas

Peter Barabas is a Research Fellow at the School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, affiliated with the Wellcome Wolfson Institute for Experimental Medicine. His work focuses on diabetic retinopathy, neurovascular integrity, and molecular mechanisms in retinal disease.

• Current affiliation: Queen's University Belfast
• Research focus: Diabetic Retinopathy, TRPV2, Endothelial Cells, Mitochondrial Dynamics

Barabas investigates the role of acrolein in diabetic retinal disease and explores gene therapy approaches like ALDH1A1. His studies often involve rat models and molecular techniques such as Western blotting and immunohistochemistry. Recent collaborations address neurovascular protection and infection-related mitochondrial dysfunction.

Peer-review activities include contributions to journals like Cells, International Journal of Environmental Research and Public Health, and Journal of Pharmacy and Pharmacology (2017-2019). His publications span experimental medicine, ophthalmology, and molecular biology, with a strong emphasis on diabetic retinopathy and related pathologies.